Insider Profile
Elliott-Stevens, Jimma
1
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
May 14, 2024
Most Recent Trade
37
Credibility
Score
89%
Hit Rate
+8.7%
Avg 90d Return
+9.4%
Median 90d Return
9
Evaluated Trades
+14.9%
Best Trade
-3.3%
Worst Trade
Hit rate and returns are based on 9 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
100%
Hit Rate · 90d
+8.6%
Median Alpha · 90d
2
Closed Buys Evaluated
100%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
cluster buyer size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 2 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
May 14, 2024 $TRI
Thomson Reuters Corp
Exercise Sell 409 58
May 14, 2024 $TRI
Thomson Reuters Corp
Exercise Buy 248 58
Mar 06, 2024 $TRI
Thomson Reuters Corp
Comp. Grant Buy 1,463 $156.94 $230K 58
Mar 06, 2024 $TRI
Thomson Reuters Corp
Comp. Grant Buy 335 58
Mar 06, 2024 $TRI
Thomson Reuters Corp
Comp. Grant Buy 670 58
Dec 15, 2023 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 22 $138.85 $3K 58
Aug 30, 2023 $TRI
Thomson Reuters Corp
Exercise Buy 800 $102.00 $82K 58
Aug 30, 2023 $TRI
Thomson Reuters Corp
Open Market Buy 800 $129.56 $104K 58
Aug 30, 2023 $TRI
Thomson Reuters Corp
Exercise Buy 1,428 58
Aug 30, 2023 $TRI
Thomson Reuters Corp
Open Market Buy 1,428 $129.50 $185K 58
Aug 30, 2023 $TRI
Thomson Reuters Corp
Exercise Sell 800 $102.00 $82K 58
Aug 30, 2023 $TRI
Thomson Reuters Corp
Exercise Sell 1,428 58
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.